Ionis Pharmaceuticals IONS Ionis Operations — Cost of Goods Sold
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's ionis operations — cost of goods sold.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's ionis operations — cost of goods sold?
- Ionis Pharmaceuticals (IONS) reported ionis operations — cost of goods sold of $2.84M in Q1 2026.
- How has Ionis Pharmaceuticals's ionis operations — cost of goods sold changed year-over-year?
- Ionis Pharmaceuticals's ionis operations — cost of goods sold increased by 108.1% year-over-year, from $1.36M to $2.84M.
- What is the long-term trend for Ionis Pharmaceuticals's ionis operations — cost of goods sold?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — cost of goods sold has grown at a 1.4% compound annual growth rate (CAGR), from $13.45M to $14.01M.
- What does ionis operations — cost of goods sold mean?
- The direct costs incurred to manufacture and deliver products to customers.
- How do you interpret ionis operations — cost of goods sold?
- A decrease relative to revenue suggests improved manufacturing efficiency or economies of scale.
- How does ionis operations — cost of goods sold compare across companies?
- Comparable to cost of revenue or cost of sales in standard financial reporting.